February 18, 2015, NIAID Funding News
Read this full issue online at http://www.niaid.nih.gov/
Critical Deadlines and Process for Investigator-Initiated Clinical Trials Investigator-initiated clinical trial applications need careful planning and have a long lead time, yet many investigators still miss key aspects of the process or start too late. Read the full article.
Opportunities and Resources
Taking a Systems Biology Approach to Antibacterial Resistance To combat infectious diseases, it's critical to have an increased understanding of the molecular mechanisms of the host and the pathogen associated with antibacterial resistant infections. Read the full article.
Research the Role of Exosomes in HIV Pathogenesis Consider applying for an R21 exploratory/developmental research grant for new research on the potential role of exosomes in HIV transmission, innate or adaptive immune responses to HIV, or HIV pathogenesis. Read the full article.
Wanted: An Assay to Determine HIV Infection Recency A missing tool in the fight against HIV/AIDS is a robust test to determine whether an HIV infection occurred within the previous year or is the result of chronic infections. Read the full article.
In The News
Follow the Rules for New Applications—Or Else When following an unfunded application with a new one, remember to abide by the rules. Read the full article.
- Register Your Small Business Now for the April Omnibus Deadline
- NIH Will Accept Applications Delayed by Winter Storms
- Small Bump in R01 Paylines
- You Can Use ASSIST to Submit R03 and R21 Applications
- NIH Soliciting Feedback on Potential Emeritus Award
- Grants.gov Upgraded to Accept Special Characters
Remember the Rules for Requesting Big Grant Preapproval An application that requests $500,000 or more in direct costs in any one year is considered a big grant. Read the full article.
- Am I required to use My Bibliography or SciENcv to list my published work in the new biosketch format?
- Can my small business establish a subaward with an NIH intramural laboratory using NIH grant money?
New Funding Opportunities
- RFA-AI-15-005, Molecular Mechanisms of Combination Adjuvants (MMCA)
See other announcements at NIAID Funding Opportunities List.
Send suggestions or comments to email@example.com.